Индукция интерферонов 1-, 2- и 3-го типов солями акридонуксусной кислоты
Аннотация
Об авторах
С. С. ГригорянРоссия
А. Ю. Петров
Россия
Е. И. Исаева
Россия
М. А. Музыкин
Россия
А. Л. Коваленко
Россия
М. Г. Романцов
Россия
Список литературы
1. Коваленко А. Л. Фармакологическая активность оригинальных лекарственных препаратов на основе І-дезокси-І(N-метиламино)-D-глюцитола. Автореф. дисс.. д.б.н. СПб.: 2005; 48.
2. Shapira S. D., Hacohen N. Systems biology approaches to dissect mammalian innate immunity. Curr Opin Immunol 2011; 23: 2373-2377.
3. Hertzog P. J. Type 1 interferons as primers, activators and inhibitors of innate and adaptive immune responses. Immunol Cell Biol 2012; 90: 471-473.
4. Hervas-Stubs S., Perez-Garcia J. L. et al. Direct effects of type 1 interferons on cells of immune system. Clin Cancer Res 2011; 17: 2619-2627.
5. Choubey D., Moudgi K. D. Interferons in autoimmune and inflammatory diseases: regulation and roles. J Interferon &Cytokine Research 2011; 12: 857-865.
6. Hillyer Ph., Mane V. P. et al. Expression profiles of human interferon-alpha and interferon-lambda subtypes are ligand- and cell-dependent. Immunol Cell Biol 2012; 90: 774-783.
7. Mordstein M., Neugebauer E. et al. Lambda interferon reders epithelial cells of respiratory and gastrointestinal tracts resistant to viral infections. Virology 2010; 11: 5670-5677.
8. Jewell N. A., Cline T. et al. Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo. Virology 2010; 11515-1122.
9. Donnelly R. P., Kotenko S. V. Interferon-lambda: a new addition to an old family. J. Interferon & Cytokin Res 2010; 8: 555-564.
10. Kotenko S. V. IFN-λs. Curr Opin Immunol 2011; 23: 1-8.
11. Levy D. E., Marie I. J. Induction of type 1 and 3 interferon in response to viral infection. Curr Opin Virol 2011; 1: 476-486.
12. Wang B. X., Fish E. N. The yen and yang of viruses and interferons. Trend Immunol 2012; 33: 190-197.
13. Интерферон - 2011. Сборник научных статей. М.: 2012.
14. Nowoslawski L., Benveniste E. N. Viral exploitation of host SOCS pro tein functions. Virology 2011; 1912-1921.
15. Forsbach A., Muller Ch. et al. Negative regulation of type 1 interferon signaling pathway. J Interferon & Cytokin Res 2012; 6: 254-268.
16. Miller R. L., Meng T. C., Tomai M. A. The antiviral activity of Toll-like receptor 7 and 7/8 agonists. Drug News Perspect 2008; 21: 2: 69-87.
17. Ahn M. Y., Kwon S. M. et al. Toll-like receptor 7 agonist, imiquimod, inhibits oral squamous carcinoma cells through apoptosis and necrosis. J Oral Pathol Med 2012; 41: 7: 540-546.
18. Puig M., Tosh K. W. et al. CpG ODN and imiquimod induce distinct type interferon responses in humans and non-human primates. J Leukoc Biol 2012; 91: 147-158.
Рецензия
Для цитирования:
Григорян С.С., Петров А.Ю., Исаева Е.И., Музыкин М.А., Коваленко А.Л., Романцов М.Г. Индукция интерферонов 1-, 2- и 3-го типов солями акридонуксусной кислоты. Антибиотики и Химиотерапия. 2014;59(9-10):3-9.
For citation:
Grigoryan S.S., Petrov A.Yu., Isaeva E.I., Muzykin M.A., Kovalenko A.L., Romantsov M.G. Induction of Type 1, 2 and 3 Interferons by Acridone Acetates. Antibiot Khimioter = Antibiotics and Chemotherapy. 2014;59(9-10):3-9. (In Russ.)